MedPath

吉林万通药业集团郑州万通复升药业股份有限公司

Ownership
-
Established
2004-03-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

49

NMPA:49

Drug Approvals

Metformin Hydrochloride and Glibenclamide Capsules(I)

Product Name
二甲双胍格列本脲胶囊(Ⅰ)
Approval Number
国药准字H20080346
Approval Date
Mar 15, 2023
NMPA

Levofloxacin Lactate Dispersible Tablets

Product Name
乳酸左氧氟沙星分散片
Approval Number
国药准字H20080517
Approval Date
Mar 15, 2023
NMPA

Telmisartan Tablets

Product Name
替米沙坦片
Approval Number
国药准字H20070121
Approval Date
Apr 6, 2022
NMPA

Cinmetacin Enteric-coated Capsules

Product Name
桂美辛肠溶胶囊
Approval Number
国药准字H41025631
Approval Date
Apr 15, 2020
NMPA

益肝灵片

Approval Number
国药准字Z41022405
Approval Date
Apr 15, 2020
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H41025661
Approval Date
Apr 15, 2020
NMPA

Tetracycline Tablets

Product Name
四环素片
Approval Number
国药准字H41025638
Approval Date
Apr 15, 2020
NMPA

Cimetidine Tablets

Product Name
西咪替丁片
Approval Number
国药准字H41025642
Approval Date
Apr 15, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H41025651
Approval Date
Apr 15, 2020
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H41025662
Approval Date
Apr 15, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.